Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Feldmann

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
JAMA|December 5, 2023
Treatment of Adults Hospitalized With COVID-19 PneumoniaPaul Mathew, Marc Feldmann
Nature Reviews. Rheumatology|October 3, 2009
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritisPeter C Taylor, Marc Feldmann
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2010
Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us?Marc Feldmann, Ravinder N Maini
Current Opinion in Pharmacology|July 15, 2004
New approaches to therapeutic immunomodulation for immune-mediated inflammatory disordersPeter C Taylor, Marc Feldmann
Joint Bone Spine|February 23, 2002
Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studiesMarc Feldmann, Ravinder N Maini
Arthritis Research|July 12, 2002
How does infliximab work in rheumatoid arthritis?Ravinder N Maini, Marc Feldmann
Current Opinion in Immunology|October 30, 2004
Emerging approaches for the therapy of autoimmune and chronic inflammatory diseaseAndrew P Cope, Marc Feldmann
Journal of the American Society of Nephrology : JASN|April 21, 2006
Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseasesMarc Feldmann, Charles D Pusey
Nature Clinical Practice. Rheumatology|January 5, 2007
The pitfalls in the development of biologic therapyRavinder N Maini, Marc Feldmann
The Journal of Clinical Investigation|January 3, 2020
A conversation with Marc Feldmann, Jacques Miller, and Max CooperMarc Feldmann, Ushma S Neill
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
JAMA|December 5, 2023
Treatment of Adults Hospitalized With COVID-19 PneumoniaPaul Mathew, Marc Feldmann
Nature Reviews. Rheumatology|October 3, 2009
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritisPeter C Taylor, Marc Feldmann
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2010
Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us?Marc Feldmann, Ravinder N Maini
Current Opinion in Pharmacology|July 15, 2004
New approaches to therapeutic immunomodulation for immune-mediated inflammatory disordersPeter C Taylor, Marc Feldmann
Joint Bone Spine|February 23, 2002
Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studiesMarc Feldmann, Ravinder N Maini
Arthritis Research|July 12, 2002
How does infliximab work in rheumatoid arthritis?Ravinder N Maini, Marc Feldmann
Current Opinion in Immunology|October 30, 2004
Emerging approaches for the therapy of autoimmune and chronic inflammatory diseaseAndrew P Cope, Marc Feldmann
Journal of the American Society of Nephrology : JASN|April 21, 2006
Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseasesMarc Feldmann, Charles D Pusey
Nature Clinical Practice. Rheumatology|January 5, 2007
The pitfalls in the development of biologic therapyRavinder N Maini, Marc Feldmann
The Journal of Clinical Investigation|January 3, 2020
A conversation with Marc Feldmann, Jacques Miller, and Max CooperMarc Feldmann, Ushma S Neill
Pageof 16